LAVA Therapeutics NV - SHS (LVTX)

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SHS
Shares, excl. options Q3 2024
3.61M
Holdings value Q3 2024
$5.99M
Value change Q3 2024
-$253K
Grand Portfolio weight change Q3 2024
0%
Number of holders
20
Number of buys Q3 2024
7
Number of sells Q3 2024
-8
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 3.61M $5.99M -$253K $1.66 20
2024 Q2 3.76M $6.77M -$68.2K $1.80 19
2024 Q1 3.76M $12.5M -$2.1M $3.33 22
2023 Q4 5.84M $9.22M +$207K $1.58 14
2023 Q3 5.72M $8.47M -$47.2K $1.49 14
2023 Q2 5.75M $11.7M -$1.82M $2.03 16
2023 Q1 6.74M $11.2M -$1.63M $1.66 19
2022 Q4 7.46M $26.3M +$105K $3.50 19
2022 Q3 7.45M $34.1M -$58.9K $4.57 12
2022 Q2 7.84M $22.8M -$450K $2.95 16
2022 Q1 8M $35.2M -$409K $4.40 16
2021 Q4 8.05M $44.3M -$914K $5.50 18
2021 Q3 8.22M $48.6M -$5.13M $5.92 17
2021 Q2 8.77M $95.5M -$5.97M $10.88 18
2021 Q1 9.22M $139M +$139M $15.19 24